OPPENHEIMER HOLDINGS INC

OPY

Explore Our Financial Data > Companies > > OPPENHEIMER HOLDINGS INC
{{popupValue}}
{{popupSubtitle}}
Documentation
Excel
API
Download

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
OPY
CIK0000791963
SIC6211
SectorFinance, Insurance, And Real Estate
Industry CategoryTrading
Industry GroupSecurity And Commodity Brokers, Dealers, Exchanges & Services

Contact

Address85 BROAD STREET, 22ND FLOOR, NEW YORK, NY, 10004
Website oppenheimer.com
Phone(212) 825-4331
CEOAlbert G. Lowenthal
Employees2,910

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$1.49 billion
Pre-Tax Income$126.02 million
Net Income$87.57 million
Net Income to Common$87.57 million
EPS$7.71
View All
Balance Sheet
Cash$37.62 million
Assets$3.69 billion
Liabilities$2.79 billion
Common Equity$896.86 million
Liabilities & Equity$3.69 billion
View All
Cash Flow Statement
Net Income$87.57 million
Cash From Operating Activities$34.48 million
Cash From Investing Activities$-3.68 million
Cash From Financing Activities$-26.39 million
Change in Cash$4.40 million
View All
Calculations
NOPAT$87.57 million
EBITDA$181.86 million
Price to Earnings$8.72
Price to Book$0.85
ROE10.25%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

ATAI Life Sciences (ATAI) Rated as ‘Outperform’ at Oppenheimer on Psychedelic Prospects

Atai Life Sciences (NASDAQ:ATAI) is one of the best multibagger penny stocks to buy according to analysts. On July 29, Oppenheimer initiated coverage of the stock with an ‘Outperform’ rating and a $14 price target. The positive stance comes as the research firm views ATAI Life Sciences as a leader in the psychedelic revolution within […]

Article Link

Oppenheimer Holdings Inc. (NYSE:OPY) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

NYSE:OPY 1 Year Share Price vs Fair Value Explore Oppenheimer Holdings's Fair Values from the Community and select...

Article Link

Aptiv Stock: Analyst Estimates & Ratings

Aptiv has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

Article Link

David Wright Joins Oppenheimer As Managing Director in the Pacific Northwest

Oppenheimer & Co. Inc. ("Oppenheimer"), a leading investment bank and wealth manager and a subsidiary of Oppenheimer Holdings Inc. (NYSE: OPY), today announced the appointment of David Wright as Managing Director and Co-Regional Manager for the Pacific Northwest.

Article Link

Should You Be Adding Oppenheimer Holdings (NYSE:OPY) To Your Watchlist Today?

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Article Link